by University of California, San Francisco In all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that cross 1, which suggests that treatment is not beneficial in reducing the risk of Long COVID. Model 3, the prespecified primary result, includes age, sex, and time...
by Kerry Noble, Imperial College London Adjusted HRs of COVID-19 hospitalization in children for different asthma status compared with children with no asthma. HRs of death COVID-19 hospitalization compared with people with no asthma, obtained from Cox regression models. Sociodemographic factors include, region, ethnicity, quintile of the Index of Multiple Deprivation. OCS, oral corticosteroids. Credit: Thorax (2022)....
UNIVERSITY OF EDINBURGH Children with poorly controlled asthma are three to six times more likely to be hospitalised with Covid-19 than those without the condition, research suggests. Experts advise that 5 to 17 year olds with poorly controlled asthma should be considered for vaccination to reduce the risk of infection and the spread of Covid-19...
by Dennis Thompson, Healthday Reporter A or B, AB or O, it doesn’t matter—your blood type has nothing to do with your risk of contracting severe COVID-19, a new study concludes. Early in the pandemic, some reports suggested people with A-type blood were more susceptible to COVID, while those with O-type blood were less so....
